USPTO serial 76113580
RAINBOW ABC
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- MICHOS, JOHN E
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with RAINBOW ABC?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Dr. Viviana Amzel
DR VIVIANA AMZEL EPIGENESIS PHARMACEUTICALS, INC7 CLARKE DRCRANBURY, NJ 08512UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | aerosol dispensers for medical use, sold filled or in a kit with, and for the delivery of pharmaceutical preparations for use in testing, and prophylactic and therapeutic treatment, of ailments, diseases and conditions associated with respiratory, airway and pulmonary diseases, such as asthma, pulmonary vasoconstriction, inflammation, allergies, asthma, impeded respiration, Acute Respiratory Distress Syndrome (ARDS), renal damage and failure, for example when associated with ischemia, administration of certain drugs, in heart and cardiovascular stress tests, side effects associated with adenosine and other compounds, such as when treating Supra Ventricular Tachycardia (SVT), infantile Respiratory Distress Syndrome (infantile RDS), pain, cystic fibrosis, allergic rhinitis, allergic bronchitis, pulmonary hypertension, pulmonary vasoconstriction, emphysema, chronic obstructive pulmonary disease (COPD), as well as cancers such as leukemias, lymphomas, carcinomas, and the like, e.g. colon cancer, breast cancer, lung cancer, pancreatic cancer, hepatocellular carcinomas, kidney cancer, melanoma, hepatic metastases, etc., as well as other metastatic cancers, e.g. cancers which metastasized to the lung(s), breast and prostate, airway diseases and conditions including those that may be associated with hyper-sensitivity or hyer-responsiveness to adenosine, bronchoconstriction, difficult breathing, impeded and obstructed lung airways, allergy(ies) and /or inflammation, which in many cases are adenosine receptor associated symptoms, and more generally for testing and treatment of human and non-human animal ailment included | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 2, 2003 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Feb 25, 2003 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Dec 3, 2002 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 13, 2002 | NPUB | NOTICE OF PUBLICATION | — |
| Sep 15, 2002 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 19, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 19, 2002 | PAPER RECEIVED | — | |
| Jul 17, 2002 | 1.BA | Sec. 1(B) CLAIM ADDED | — |
| Jul 17, 2002 | 1.AD | SEC. 1(A) CLAIM DELETED | — |
| Jul 17, 2002 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 31, 2001 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Aug 9, 2001 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 1, 2001 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 4, 2001 | DOCK | ASSIGNED TO EXAMINER | — |